AXIM BIOTECHNOLOGIES, INC. (AXIM) Form 10-Q Quarterly Reports
AXIM BIOTECHNOLOGIES, INC. (AXIM) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: AXIM
CIK: 1514946
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
RBSM LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerRAJESH SHARMA
Audit LocationNEW YORK, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 15-12G | 2024-12-06 | — | AXIM BIOTECHNOLOGIES, INC. FORM 15-12G | 0001096906-24-002227 | View SEC Doc Filr Page |
| NT 10-Q | 2024-11-13 | 2024-09-30 | AXIM BIOTECHNOLOGIES, INC._FORM NT 10-Q | 0001096906-24-002103 | View SEC Doc Filr Page |
| 4 | 2024-10-15 | 2024-01-30 | PRIMARY DOCUMENT | 0001096906-24-002004 | View SEC Doc Filr Page |
| 8-K | 2024-10-15 | 2024-10-09 | AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING | 0001096906-24-002002 | View SEC Doc Filr Page |
| 10-Q | 2024-08-19 | 2024-06-30 | FORM 10-Q | 0001096906-24-001772 | View SEC Doc Filr Page |
| NT 10-Q | 2024-08-13 | 2024-06-30 | AXIM BIOTECHNOLOGIES FORM 12B-25 | 0001096906-24-001686 | View SEC Doc Filr Page |
| 10-Q/A | 2024-05-22 | 2024-03-31 | FORM 10-Q/A | 0001096906-24-001225 | View SEC Doc Filr Page |
| 10-Q | 2024-05-20 | 2024-03-31 | FORM 10-Q | 0001096906-24-001202 | View SEC Doc Filr Page |
| NT 10-Q | 2024-05-15 | 2024-03-31 | AXIM BIOTECHNOLOGIES FORM 12B-25 | 0001096906-24-001124 | View SEC Doc Filr Page |
| 10-K | 2024-04-16 | 2023-12-31 | FORM 10-K | 0001096906-24-000864 | View SEC Doc Filr Page |
| NT 10-K | 2024-04-01 | 2023-12-31 | AXIM BIOTECHNOLOGIES, INC. - NT 10K | 0001096906-24-000689 | View SEC Doc Filr Page |
| 8-K | 2024-03-21 | 2024-03-15 | AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING | 0001096906-24-000539 | View SEC Doc Filr Page |
| 4/A | 2024-03-19 | 2024-03-15 | PRIMARY DOCUMENT | 0001096906-24-000525 | View SEC Doc Filr Page |
| 4 | 2024-03-19 | 2024-03-15 | PRIMARY DOCUMENT | 0001096906-24-000524 | View SEC Doc Filr Page |
| 4 | 2024-03-19 | 2024-03-15 | PRIMARY DOCUMENT | 0001096906-24-000522 | View SEC Doc Filr Page |
| 4 | 2024-03-19 | 2024-03-15 | PRIMARY DOCUMENT | 0001096906-24-000520 | View SEC Doc Filr Page |
| 4 | 2024-03-19 | 2024-03-15 | PRIMARY DOCUMENT | 0001096906-24-000517 | View SEC Doc Filr Page |
| 4 | 2024-03-19 | 2024-03-15 | PRIMARY DOCUMENT | 0001096906-24-000515 | View SEC Doc Filr Page |
| 4 | 2024-03-19 | 2024-03-15 | PRIMARY DOCUMENT | 0001096906-24-000511 | View SEC Doc Filr Page |
| 4 | 2024-03-19 | 2024-03-15 | PRIMARY DOCUMENT | 0001096906-24-000509 | View SEC Doc Filr Page |
| 8-K | 2024-02-13 | 2024-02-07 | AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING | 0001096906-24-000199 | View SEC Doc Filr Page |
| 8-K | 2023-12-28 | 2023-12-26 | AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING | 0001096906-23-002456 | View SEC Doc Filr Page |
| 10-Q | 2023-11-20 | 2023-09-30 | FORM 10-Q | 0001096906-23-002238 | View SEC Doc Filr Page |
| NT 10-Q | 2023-11-14 | 2023-09-30 | AXIM BIOTECHNOLOGIES, INC._FORM NT 10-Q | 0001096906-23-002168 | View SEC Doc Filr Page |
| DEF 14C | 2023-09-21 | 2023-09-21 | AXIM BIOTECHNOLOGIES, INC. - DEF14C | 0001096906-23-001823 | View SEC Doc Filr Page |